THE FIRST-LINE TREATMENT OF ITP IS

• A. Administration of corticosteroids ✓
• B. Administration of intravenous immunoglobulin (IVIG)
• C. A splenectomy
• D. Administration of azathioprine

The first-line treatment for Immune Thrombocytopenic Purpura (ITP) is the administration of corticosteroids. Corticosteroids, such as prednisone or dexamethasone, are commonly used to suppress the immune system’s attack on platelets in ITP. They work by reducing inflammation and decreasing the destruction of platelets by the immune system.

Corticosteroids are often effective in raising platelet counts in patients with ITP. However, long-term use of corticosteroids may lead to side effects such as weight gain, mood changes, and increased risk of infections. Therefore, the duration of corticosteroid therapy should be carefully monitored by healthcare providers.

In cases where corticosteroids are not effective or if there is a need for additional treatment options, other therapies such as intravenous immunoglobulin (IVIG), splenectomy, or immunosuppressive medications like azathioprine may be considered.

In summary, the initial approach to managing ITP typically involves the administration of corticosteroids due to their effectiveness in increasing platelet counts and controlling symptoms associated with low platelet levels.